3.Pledges in the Past G8 Summits

• We shall continue to see to work with developing countries, so as to help them to fight hunger and disease...

• We pledge ourselves afresh to fight against hunger, disease.

• Heads of State or Government and the representatives of the European Coummunity affirm that AIDS is one of the biggest potential health problems in the world.

• We take note of the creation of an International Ethics Committee on AIDS.

• The goals of a new partnership for development should include improved health.
• The objective of this new partnership includes giving more explicit priority to sustainable development and alleviation of poverty. This should mean adequate ODA funding of essential sectors such as health...

• (In relation to the new partnership) we emphasize the usefulness of indicators capable of measuring progress toward development objectives in specific countries in areas such as extremem poverty, infant, child and maternal mortality...

• we endorse the creation and implementation mechanisms to aid in the prevention, detection, surveillance and response to the emergence and re-emergence of communicable diseases.
• we reiterate our call for the extension of all forms of cooperation in the realms of research, prevention, accessible and affordable health care services and diagnostics in the treatment and control of these diseases.
• We pledge to support this effort (measures already undertaken in each of our countries to encourage scientific community in its search for remedies to these diseases) at the national level, while at the same time promoting international cooperation among research teams in this field.
• continue to extend various kinds of assisstance programs, in particular for the benefit of the countries hardest hit by HIV/AIDS and other infectious diseases.
• encourage cooperation among those of us who jointly conduct cooperatie projects with Africa, S Asia, Latin America and the Carribean by transferring our expertise in regard to surveillance, prevention, research, diagnosis, and treatment of these diseases.
• continue to work to ensure that availability of safe and effective treatments for these all-too-often diseases.
• we strongly support the efforts of the WHO and UNAIDS.

• we will work with African countries to ensure adequate and well-targeted assistance for those countries which have the greatest need and carry out the necessary broad based reforms. This assisstance will include…environmental protection and human resource development, including health and education of their people.

• in the coming year, our governments will promote more effetive coordination of international responses to outbreaks; promote development of a global surveillance network, building upon exisitng nationa and regional surveillance systems; and help to build public health capacity to prevent, detect and control infectious diseases globally including efforts to explore the use of regional stocks of essential vaccines, therapeutics, diagnostics and other materials.
• ・ we support the efforts of the WHO and the recent World Health Assembly resolutions regarding the quality of biological and pharmaceutical products.

• we will work to provide the resources necessary to accelerate AIDS vaccine research, and together will enhance international scientific cooperation and collaboration.
• we will work to assure that it (UNAIDS) has resources adequate to fulfill its mandate.

• we will continue of efforts to reduce the global scourage of AIDS through vaccine development, preventive programmes and appropriate therapy, and by our continued support for UNAIDS.
• we welcome the French proposal for the 'Therapeutic Solidarity Initiative' and other proposals for teh preveniton and treatement of AIDS, and request our esperts to examine speedily the feasibility of their implementation.

• we support the new initiative to "Roll Back Malaria" to relieve the suffering experienced by hundreds of millions of people, and significantly reduce the death rate from malaria by 2010.

• We reaffirm the need to continue efforts to combat AIDS at the national and international level through a combined strategy of prevention, vaccine development and appropriate therapy.
• We welcome and support the coordinating and catalytic role of the UNAIDS in the fight against AIDS.
• We call on co-sponsors and other partners to cooperate in the formulation of clear goals, strategies and initiatives at botht eh global and regionel level.

• We also pledge to continue our national and international efforts in the fight against infectious and parasitic diseases, such as malaria, polio and TB, and their drug-resistant forms.
• we will continue to support the endeavors of the WHO and its initiatives "Roll Back Malaria" and "Stop TB". We call on the governments top adopt these recommended strategies.

• We also agree to give special attention to three issues - ...health... as a spur to growth.

• (Commit to) mobilising the instruments and resources of the international community to support and reinforce the efforts of these countries to combat and overcome these challenges（HIV/AIDS Pandemic, slow growth), with particular priority on promoting equitable distribution of the benefits of growth through sound social policies, including regarding health and education.
• we have agreed to: Implement an ambitious plan on infectious diseases, notably HIV/AIDS, malaria and tuberculosis (TB)
• We... commit ourselves to working in strengthened partnership with governments, the WHO and other IOs, industry (notably pharmaceutical companies), academic institutions, NGOs and other relevant actors in CS to deliver three critical UN targets:　（１） Reduce the number of HIV/AIDS-infected young people by 25% by 2010; （２）Reduce TB deaths and prevalence of the disease by 50% by 2010; （３）Reduce the burden of disease associated with malaria by 50% by 2010.
• In order to achieve this ambitious agenda our partnership must aim to cover:
  • - Mobilising additional resources ourselves, and calling on the MDBs to expand their own assistance to the maximum extent possible;
  • Giving priority to the development of equitable and effective health systems, expanded immunisation, nutrition and micro-nutrients and the prevention 　and treatment of infectious diseases;
  • - Promoting political leadership through enhanced high-level dialogue designed to raise public awareness in the affected countries;
  • - Committing to support innovative partnerships, including with the NGOs, the private sector and multilateral organisations;
  • - Working to make existing cost-effective interventions, including key drugs, vaccines, treatments and preventive measures more universally available and affordable in developing countries;
  • - Addressing the complex issue of access to medicines in developing countries, and assessing obstacles being faced by developing countries in that regard;
  • - Strengthening co-operation in the area of basic research and development on new drugs, vaccines and other international public health goods.
• We note with encouragement new commitments in these areas. We strongly welcome the World Bank's commitment to triple International Development Association (IDA) financing for HIV/AIDS, malaria, and TB. We also welcome the announcements to expand assistance in this area made by bilateral donors.
• We will convene a conference in the autumn this year in Japan to deliver agreement on a new strategy to harness our commitments. We will take stock of progress at the Genoa Summit next year and will also work with the UN to organise a conference in 2001 focusing on strategies to facilitate access to AIDS treatment and care.

• Our partnership will support the key themes of the New African Initiative, including:
  • Human development, by investing in health and education, and tackling HIV/AIDS, TB and malaria, including through the Global AIDS and Health Fund.

• we have launched with the UN Secretary-General a new Global Fund to fight HIV/AIDS, malaria and tuberculosis. We have committed $1.3 billion. The Fund will be a public-private partnership and we call on other countries, the private sector, foundations, and academic institutions to join with their own contributions - financially, in kind and through shared expertise. We welcome the further commitments already made amounting to some $500 million.
• The Fund will promote an integrated approach emphasising prevention in a continuum of treatment and care. It will operate according to principles of proven scientific and medical effectiveness, rapid resource transfer, low transaction costs, and light governance with a strong focus on outcomes. We hope that the existence of the Fund will promote improved co-ordination among donors and provide further incentives for private sector research and development. It will offer additional financing consistent with existing programmes, to be integrated into the national health plans of partner countries. The engagement of developing countries in the purpose and operation of the Fund will be crucial to ensure ownership and commitment to results. Local partners, including NGOs, and international agencies, will be instrumental in the successful operation of the Fund.
• Strong national health systems will continue to play a key role in the delivery of effective prevention, treatment and care and in improving access to essential health services and commodities without discrimination…We welcome the steps taken by the pharmaceutical industry to make drugs more affordable. In the context of the new Global Fund, we will work with the pharmaceutical industry and with affected countries to facilitate the broadest possible provision of drugs in an affordable and medically effective manner. We welcome ongoing discussion in the WTO on the use of relevant provisions in the Trade-Related Intellectual Property Rights (TRIPs) agreement. We recognise the appropriateness of affected countries using the flexibility afforded by that agreement to ensure that drugs are available to their citizens who need them, particularly those who are unable to afford basic medical care. At the same time, we reaffirm our commitment to strong and effective intellectual property rights protection as a necessary incentive for research and development of life-saving drugs.

• Supporting health research on diseases prevalent in Africa, with a view to narrowing the health research gap, including by expanding health research networks to focus on African health issues, and by making more extensive use of researchers based in Africa.

• Measures for disadvantaged children should be included in national education plans:AIDS-affected children: There are now more than 13 million AIDS orphans; this number is projected to reach 35 million by 2010. The unique circumstances of AIDS orphans will require creative-often unique-solutions. Community groups can play an important role.

We committ to: Helping Africa combat the effects of HIV/AIDS - including by:

• Supporting programmes that help mothers and children infected or affected by HIV/AIDS, including children orphaned by AIDS;
• Supporting the strengthening of training facilities for the recruiting and training of health professionals;
• Supporting the development, adoption and implementation of gender-sensitive, multi-sectoral HIV/AIDS programs for prevention, care, and treatment;
• Supporting high level political engagement to increase awareness and reduce the stigma associated with HIV/AIDS;
• Supporting initiatives to improve technical capacity, including disease surveillance;
• Supporting efforts to develop strong partnerships with employers in increasing HIV/AIDS awareness and in providing support to victims and their families;
• Supporting efforts that integrate approaches that address both HIV/AIDS and tuberculosis; and,
• Helping to enhance the capacity of Africa to address the challenges that HIV/AIDS poses to peace and security in Africa.

• The impact of HIV/AIDS on the teaching profession and the operations of schools must be acknowledged and addressed in national educational plans. Technical assistance to help countries address the impacts of HIV/AIDS on the supply, demand, and quality of education, including the effect on teachers, can make an important contribution to these strategies.
• A country's education system can perform a constructive role in equipping people to address-and ultimately reverse-the devastating spread of this disease. Teachers can play an important role in reinforcing the importance of prevention. In these circumstances, the proper training of teachers is essential.

We committ to:
6.2 Supporting African efforts to build sustainable health systems in order to deliver effective disease interventions - including by:

• Pressing ahead with current work with the international pharmaceutical industry, affected African countries and civil society to promote the availability of an adequate supply of life-saving medicines in an affordable and medically effective manner;
• Supporting African countries in helping to promote more effective, and cost-effective, health interventions to the most vulnerable sectors of society - including reducing maternal and infant mortality and morbidity;
• Continuing support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, and working to ensure that the Fund continues to increase the effectiveness of its operations and learns from its experience;
• Supporting African efforts to increase Africa's access to the Global Fund and helping to enhance Africa's capacity to participate in and benefit from the Fund;
• Providing assistance to strengthen the capacity of the public sector to monitor the quality of health services offered by both public and private providers; and,
• Supporting and encouraging the twinning of hospitals and other health organizations between G8 and African countries.

• l We committ to:
  6.3 Accelerating the elimination and mitigation in Africa of polio, river blindness and other diseases or health deficiencies - including by:
  • Providing, on a fair and equitable basis, sufficient resources to eliminate polio by 2005; and,
  • Supporting relevant public-private partnerships for the immunization of children and the elimination of micro-nutrient deficiencies in Africa.

• Global health crises call for close international co-operation on policies and methods. We reaffirm our commitment to achieving the development goals set out in the Millennium Summit and at the World Summit on Sustainable Development. We will work in partnership with developing countries, the private sector, multilateral organisations and non-governmental organisations (NGOs) to help achieve these health goals. Multilateral and bilateral Official Development Aid as well as private efforts from companies and NGOs should match and complement existing efforts to improve health outcomes.

• We welcome the increased bilateral commitments for HIV/AIDS, whilst recognising that significant additional funds are required. We commit, with recipient countries, to fulfil our shared obligations as contained in the Declaration of Commitment on HIV/AIDS for the 2001 United Nations General Assembly Special Session.
• We reaffirm our support for the Global Fund to fight AIDS, Tuberculosis, and Malaria.
• We welcome and support the proposal to host, in collaboration with the Global Fund, an international donors' and supporters' conference bringing together governments, international organisations, NGOs and members of the private sector active in this field in Paris this July. The purpose will be to develop strategies for mobilising resources in order to secure sustainable long term financing for the Fund and other complementary efforts, and to achieve cost effective results-targeted management of the Global Fund.
• We call upon those that have not yet done so to consider increasing their support to the Global Fund as well as to other multilateral and bilateral efforts to combat these infectious diseases.

• Building on strengthened health systems, in partnership with others, including public-private partnerships, we will work to develop an integrated approach that will facilitate the availability and take-up of discounted medicines for the poorest in a manner that is fair, efficient and sustainable. We recognise the complexity of increasing access to medicines in developing countries which, among other factors, depends on affordable prices. We welcome pharmaceutical companies' voluntary long-term commitments to providing essential medicines at substantially discounted prices to developing countries and strongly encourage further efforts, including through supply competition. We will also work with developing countries to encourage greater uptake of such offers of free and discounted drugs, as are now being made. We support and encourage developing countries to contribute to the goal of affordable medicines by reducing their tariffs and fees on discounted and donated products.
• We will take the steps necessary to prevent the diversion of those medicines away from the countries or regions for which they were intended. We call on recipient governments to do the same and we undertake to provide technical support to assist them to do so. We will not use the preferential prices offered to the developing world as benchmarks for pharmaceutical products on our own markets.
• To address the practical problems faced by developing countries with no or insufficient manufacturing capacities, we note that, pending a WTO solution, many of us have instituted moratoria on challenging any Member of the WTO that, according to the scope and modalities defined in their respective moratoria, would want to export to a country in need medicines produced under compulsory license for addressing public health crises, including those relating to HIV/AIDS, tuberculosis and malaria and other epidemics. We direct our ministers and officials, working urgently with WTO partners, to establish a multilateral solution in the WTO to address the problems faced by these countries, rebuilding the confidence of all parties, before the Cancun Ministerial.

• We reaffirm our commitment to combating the global HIV/AIDS pandemic.Both individually and collectively, we have increased our efforts aimed at HIV treatment, care, and prevention. We acknowledge the important role of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, UNAIDS, and WHO in fighting this pandemic. But the human and economic toll of the AIDS pandemic demands that these activities be complemented by accelerated efforts to develop an HIV vaccine.
• The best way to meet these challenges is for scientists around the world to work together in a complementary manner.
• We believe the time is right for the major scientific and other stakeholders -- both public and private sector, in developed and developing countries -- to come together in a more organized fashion.
• We endorse this concept and call for the establishment of a Global HIV Vaccine Enterprise.
• The Enterprise should establish a strategic plan that would prioritize the scientific challenges to be addressed, coordinate research and product development efforts, and encourage greater use of information sharing networks and technologies.
• • Encourage the development of a number of coordinated global HIV Vaccine Development Centers...
  • Stimulate the development of increased dedicated HIV vaccine manufacturing capacity...
  • Establish standardized preclinical and clinical laboratory assessment...
  • Expand an integrated international clinical trials system...
  • Optimize interactions among regulatory authorities
  • Encourage greater engagement by scientists from developing countries...
• We call on all stakeholders in the Global HIV Vaccine Enterprise to complete the development of this strategic plan by our next Summit.
• The United States, in its role as president of the G8, will convene later this year a meeting of all interested stakeholders in the Enterprise to encourage their collaborative efforts in HIV vaccine development. This meeting should clarify how the strategic plan is to be implemented. We support this conference becoming an annual event and we look forward to a report on the follow-up of the Initiative at the next G8 Summit.

• We will take all necessary steps to eradicate polio by 2005.
• To ensure that polio does not reemerge, we will work to ensure the full integration of necessary measures in national health strategies and structures in the post-eradication period through 2008.
• We are pleased that the financing gap for 2004 has now been closed through our efforts and those of others. We are determined to close the 2005 financing gap by the 2005 G8 Summit through contributions from the G8 and other public and private donors.
• We urge governments that have pledged money for polio eradication to turn their pledges into real contributions. We will work to ensure that contributions are made in a timely manner so as to enable budgeting and planning for effective immunization campaigns from now through 2005.
• We will also remain engaged with the governments of the six polio-endemic countries and the nine countries in which polio is now spreading to urge them to take stronger steps to contain and destroy the polio virus. We will also engage other donors and organizations to help support and encourage these countries.
• The G8 welcomes the resolution on polio eradication passed by the Organization of the Islamic Conference Summit held in Malaysia, from 16-17 October 2003, as another example of partnership in the effort to eradicate polio.
• The G8 recognizes the excellent work of the Polio Eradication Initiative and the special contribution made by Rotary International, through direct financial contributions and the engagement of thousands of volunteers throughout the world.

• We support our African partners' commitment to ensure that by 2015 all children have access to and complete free and compulsory primary education of good quality, and have access to basic health care (free wherever countries choose to provide this) to reduce mortality among those most at risk from dying from preventable causes, particularly women and children; and so that the spread of HIV, malaria and other killer diseases is halted and reversed and people have access to safe water and sanitation.

• (e) Building on the valuable G8 Global HIV/AIDS vaccine enterprise, increasing direct investment and taking forward work on market incentives, as a complement to basic research, through such mechanisms as Public Private Partnerships and Advance Purchase Commitments to encourage the development of vaccines, microbicides and drugs for AIDS, malaria, tuberculosis and other neglected diseases. We note continuing work to explore establishing an International Centre for Genetic Engineering & Biotechnology centre in Africa to help research into vaccines for the diseases that are afflicting the continent.

• We will work to achieve these aims by:
• (a) Working with African governments, respecting their ownership, to invest more in better education, extra teachers and new schools. This is made more crucial by the number of teachers dying from AIDS.
• We will work to achieve these aims by:
• (d) With the aim of an AIDS-free generation in Africa, significantly reducing HIV infections and working with WHO, UNAIDS and other international bodies to develop and implement a package for HIV prevention, treatment and care, with the aim of as close as possible to universal access to treatment for all those who need it by 2010. Limited health systems capacity is a major constraint to achieving this and we will work with our partners in Africa to address this, including supporting the establishment of reliable and accountable supply chain management and reporting systems. We will also work with them to ensure that all children left orphaned or vulnerable by AIDS or other pandemics are given proper support. We will work to meet the financing needs for HIV/AIDS, including through the replenishment this year of the Global Fund to fight AIDS, TB and Malaria; and actively working with local stakeholders to implement the '3 Ones' principles in all countries.

• Working with African countries to scale up action against malaria to reach 85% of the vulnerable populations with the key interventions that will save 600,000 children's lives a year by 2015 and reduce the drag on African economies from this preventable and treatable disease. By contributing to the additional $1.5bn a year needed annually to help ensure access to anti-malaria insecticide-treated mosquito nets, adequate and sustainable supplies of Combination Therapies including Artemisin, presumptive treatment for pregnant women and babies, household residual spraying and the capacity in African health services to effectively use them, we can reduce the burden of malaria as a major killer of children in sub-Saharan Africa.

• Helping to meet the needs identified by the Stop TB Partnership. We also support the call for a high-level conference of Health Ministers for TB in 2006.

• Investing in improved health systems in partnership with African governments, by helping Africa train and retain doctors, nurses and community health workers. We will ensure our actions strengthen health systems at national and local level and across all sectors since this is vital for long-term improvements in overall health, and we will encourage donors to help build health capacity.

• Supporting the Polio Eradication Initiative for the post eradication period in 2006-8 through continuing or increasing our own contributions toward the $829 million target and mobilising the support of others. We are pleased that the funding gap for 2005 has been met.

• The commitments of the G8 and other donors will lead to an increase in official development assistance to Africa of $25 billion a year by 2010, more than doubling aid to Africa compared to 2004.
• On the basis of donor commitments and other relevant factors, the OECD estimates that official development assistance from the G8 and other donors to all developing countries will now increase by around $50 billion a year by 2010, compared to 2004.

• We pledge our continued support to　UNAIDS,　WHO, GAFTM, WB and other organizations, initiatives and partnerships actively working to fight these diseases （HIV/AIDS, tuberculosis (TB) and malaria.
• We note the possibility of WTO Members to use the flexibilities in the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), as well as the compulsory licensing solution of 30 August, 2003 to enable developing countries without manufacturing capacity in the pharmaceutical sector to import medicines they need. We note that despite certain achievements, many countries still cannot get access to safe, effective and affordable medicines for those in need.
• We call for a wider use of strategies and tools that promote investment in the research, development and production of vaccines, microbicides and drugs for HIV, tuberculosis, malaria and other diseases, and that assist in scaling up access to these means of prevention and treatment through innovative clinical research programs, private-public partnerships and other innovative mechanisms. In this regard, we take note of the steps taken on voluntary innovating financing mechanisms and other funding initiatives, the details of which are set out in the annex.
• we are committed to strengthening cooperation with regulatory authorities in developing countries and to working with them on identifying appropriate standards and pathways for swift regulatory approval of new prevention and treatment methods
• We call for wider recognition of the rapidly increasing problem of antimicrobial drug resistance. We encourage increased mobilization of efforts to address this problem of global dimensions.
• We encourage governments around the world to consider eliminating import tariffs and non-tariff barriers on medicines and medical devices, where appropriate, as a measure to reduce further the cost of healthcare for the poor, and expand their access to effective treatments.

• Combating this disease（HIV/AIDS) will continue to be one of our top priorities. We remain committed to halting and reversing the spread of HIV/AIDS, as called for in the MDGs, and to the objectives outlined in the Gleneagles Summit Communique, and the call in the UNGASS on HIV/AIDS of June 2006 for scaling up significantly towards the goal of UA to comprehensive prevention programs, treatment, care and support by 2010.
• We welcome the focus by the Africa Partnership Forum on HIV/AIDS this year, the first Conference on HIV/AIDS in Eastern Europe and Central Asia in May 2006 in Moscow and the XVI International AIDS Conference in Toronto in August 2006, where the world community will address the theme 'Time to Deliver.'
• In our response to HIV/AIDS, we will adhere to the following principles:
  1. further promotion of a comprehensive and well-balanced approach to tackling HIV/AIDS, which includes prevention, treatment and care;
  2. continued involvement of all relevant partners, including CS, the private sector and people living with HIV/AIDS, in the activities to tackle the HIV/AIDS pandemic and to reduce stigma and discrimination against people with this disease;
  3. ) scale up support to address the rising rates of HIV infection among young people, particularly young girls and women;
  4. supporting the continued implementation of comprehensive, evidence-based strategies of prevention, and the development of new and innovative methods of prevention, such as microbicides, and vaccines against the diseases that increase the risk of HIV transmission;
  5. facilitating access to prevention, treatment and care for the most vulnerable segments of the population;
  6. building the capacity of health care systems in poor countries through recruitment, training and deployment of public and private health workers; and raising public awareness of the existing threat in all countries affected.
• We remain committed to our Sea Island Summit initiative on creation of a Global HIV Vaccine Enterprise, and reaffirm our determination to bring it to fruition. We welcome the Russian proposal to establish a regional coordination mechanism to promote HIV vaccine development in the countries of Eastern Europe and Central Asia, and call for this initiative to be carefully coordinated with the Global HIV Vaccine Enterprise. We also welcome coordination of activities and the cooperation between the Global HIV Vaccine Enterprise and other global initiatives and North/South partnerships active in this field, such as the European and Developing countries Clinical Trials Partnership (EDCTP) on clinical trials in Africa.

• To address this urgent situation (malaria), we:
  1. reaffirm our commitment to work with African countries to scale up malaria control interventions, reduce the burden of the disease, and eventually defeat malaria on the continent and meet the Abuja target of halving the burden of malaria by 2010
     agree to strengthen malaria control activities and programs in African countries with the objective of achieving significant public health impact;
  2. will collaborate with governments, private sector companies and NGOs in public-private partnerships to expand malaria interventions and programs;
  3. support the development of new, safe, and effective drugs, creation of a vaccine, and promotion of the widest possible availability of prevention and treatment to people in need;
  4. welcome efforts in the framework of the "Roll Back Malaria Partnership" and support activities of public and private entities to save children from the disease
  5. we commit ourselves to a regular review of our work in the field of tackling these three pandemics.

• l We reaffirm the commitment we made at the Genoa Summit in 2001 to halt the spread of this disease (TB). We will also support the Global Plan to Stop TB, 2006-2015, which aims to cut TB deaths in half by the year 2015 compared to 1990 levels, saving some 14 million lives over ten years, and call upon all donors and stakeholders to contribute to its effective implementation.
• l We note with concern the rate of HIV/AIDS and tuberculosis co-infection and seek to promote unified coordination for activities in this regard.

• We reaffirm our partnership with African nations and with the AU, and will continue to work with them to deliver on the goals of the NEPAD, to improve health systems overall and to fight infectious diseases.
• The limited capacity of health systems is a major barrier to coming as close as possible to universal access to treatment for those who need it by 2010 and has an impact on other related health outcomes such as maternal mortality and mother-to-child transmission of HIV/AIDS, hindering comprehensive, effective, evidence-based prevention, and providing care. In this regard, we agree to continue to support efforts by developing country partners, particularly in Africa, to ensure that initiatives to reduce the burden of disease are built on sustainable health systems. We will also continue to emphasize the training, deployment and retention of health workers in our health sector assistance programs. In this regard, we take note of the creation of the Global Health Workforce Alliance, and encourage further work by the WHO and other donor organizations in this area.
• We encourage stepped-up discussion at the international level on practical approaches to the expansion of public, private and community-based health insurance coverage in developing countries.. We invite the OECD and appropriate organizations to work on this issue. We welcome France's offer to host a high level meeting on this issue by the end of 2006.

• The Global Fund is an important instrument in the battle against HIV/AIDS. We will work with other donors and stakeholders in the effort to secure funds needed for the 2006-2007 replenishment period and call upon all concerned to participate actively in the development of a four-year strategy, aimed at building a solid foundation for the activities of the Fund in the years ahead.
• The G8 members will work with governments and technical agencies to support the preparation of high quality, timely proposals for Global Fund AIDS, Tuberculosis and Malaria grants.

• we support immediate implementation of the provisions of the revised International Health Regulations considered relevant to the risk posed by avian and pandemic influenza. We will comply with the provisions, including those related to rapid and transparent notification, and to provision of essential information...
• We urgently call for mobilization of financial support and will continue to work collectively and with bilateral and multilateral donors to close the funding gap for 2007-2008, and will continue to work with others towards securing the resources necessary to finish the program and declare our planet polio-free in the near future.
• We will work with other donors and stakeholders to maintain this network（existing polio monitoring network) after polio has been eradicated, with a view to supporting other public health objectives, in particular those related to disease monitoring.
• We will continue our support for the Measles Initiative launched in 2001 and will work towards a steady decrease in the number of measles-related deaths, progress in halting the spread of measles in regions and countries, and its eventual elimination.
• We will assist the Global Measles Partnership and encourage the WHO to continue to implement its plans on measles prevention and elimination, as mandated by the World Health Assembly in 2004, and to propose measures donors and national governments should take to reach and maintain a high level of immunity to measles.
• We must also increase our efforts in the fight against other preventable diseases, including pneumonia, diarrhea and neglected diseases such as leishmaniasis, Chagas disease and onchocerciasis, particularly by increasing the volume and quality of medical research on neglected diseases in developing countries.

• We focused on the issue of disaster risk reduction at Gleneagles and outlined the need for a series of practical measures, in particular through strengthened early-warning systems, as well as improved coordination and prompt humanitarian relief efforts...

• The G8 countries will scale up their efforts to contributing towards the goal of UA to comprehensive HIV/AIDS prevention programs, treatment and care and support by 2010 for all, and to developing and strengthening health systems so that health care, especially primary health care, can be provided on a sustainable and equitable basis...with particular attention paid to the needs of those most vulnerable to infection, including adolescent girls, women and children.
• Recognize that meeting this goal of UA as well as realizing the MDG for fighting HIV/AIDS, malaria and tuberculosis on a sustainable basis and strengthening of health systems will require substantial resources.

• We will support responding to those African countries that indicate that they require technical assistance and capacity building programmes for advancing their access to affordable, safe, effective and high quality generic and innovative medicines in a manner consistent with the WTO.
• The G8 reiterate their support for the work of WHO including its prequalification program and for regulatory authorities to help assure the safety, efficacy, and quality of pharmaceutical drugs, including those produced locally, in particular for second-line antiretroviral treatment and for the newly developed more effective treatment for malaria.

• The G8 will support the nationwide inclusion of appropriate HIV/AIDS-related information... in school curricula...as well as prevention information with regard to malaria and other relevant health topics.
• The G8 will emphasize the importance of programs to promote and protect human rights of women and girls as well as the prevention of sexual violence and coercion especially in the context of preventing HIV/AIDS infections.
• The G8 will take concrete steps to work toward improving the link between HIV/AIDS activities and SRH and voluntary Family Planning programs, to improve access to health care, including PMTCT, and to achieve the MDG by adopting a multisectoral approach and by fostering community involvement and participation.
• we will contribute substantially　with other donors to work towards the goal of providing universal coverage of PMTCT programs by 2010. The cost to reach this target, as estimated by UNICEF, is US$ 1,5 billion. The G8 together with other donors will work towards meeting the needed resources for paediatric treatments in the context of UA, at a cost of US$ 1,8 billion till 2010, estimated by UNICEF. We will also scale up efforts to reduce the gaps, in the area of maternal and child health care and voluntary VFP, an estimated US$ 1,5 billion.
• The G8 reaffirm their commitment to scaling up towards "UA" to comprehensive HIV prevention, treatment and care by 2010 and recognise the significant progress made by countries on target setting and planning, notably concerning enhanced availability of affordable antiretroviral treatment. Today one of the core challenges is for countries in Africa to continue to improve health systems in a comprehensive manner. We will therefore work with UNAIDS, WHO, WB and the GF to strengthen their efforts and work together with the African Union and African States, the innovative and generic pharmaceutical industry, private donors, civil society and other relevant stakeholders to help deliver next steps towards "universal access". Costed sustainable and evidence-based national AIDS plans will be key to delivering this goal. In particular we will work with:
  • ◎ African Governments:
    • to strengthen and finance health systems and make them more efficient with constructive support of donors and the relevant international organizations such as WHO and World Bank,
    • to contribute to the provision of affordable and quality medicines by eliminating or substantially reducing import tariffs and taxes with the aim to exempt price-reduced or subsidised medicines from these levies as soon as possible and examining logistics and governance issues that may hinder access,
    • to strengthen procurement practices, ensuring accountability and transparency and to review the currently existing drug and device registration policies with the aim of facilitating timely access to safe, affordable and effective HIV/AIDS drugs and medical devices,
    • to develop country-led policies that can ensure effective coordination of donor health programs and identify technical assistance needs, with the support of the WHO, World Bank, UNAIDS, GFATM and other agencies.
  • ◎ International Organizations and donors:
    • to support country-led efforts to improve coordination between all relevant stakeholders to develop costed, inclusive, sustainable, credible and evidence-based national AIDS plans which ensure effective links to health system strengthening,
    • to intensify their efforts to assist countries in setting up a workable forecasting system for pharmaceutical demand,
    • to respond constructively to requests by African developing countries without manufacturing capacities with regard to the use of the flexibilities referenced in the WTO Doha declaration on TRIPS and Public Health, while respecting WTO obligations,
    • to continue to support investments in research and development of new medicines, microbicides and vaccines, including by promoting policies that encourage innovation.
  • ◎ The Pharmaceutical Industry:
    • to continue to explore further initiatives to provide enhanced access to HIV medicines at affordable prices and to review price policies with regard to second-line antiretroviral drugs.
    • to consider supporting local production of HIV/AIDS pharmaceuticals by voluntary licences and laboratory capacities that meet international standards and strengthen regulatory, certification and training institutes.
    • to build on their expressed commitment to increase investment in research and development of new medicines, microbicides and vaccines also by extending public-private partnership.
• We welcome the decisions of the UN General Assembly to give UNAIDS the mandate to report and monitor progress towards the goal of universal access and to assist country-processes by providing a regular assessment of the status of countries' integrated plans and their financing as part of the annual monitoring of the epidemic. We encourage African parliamentarians and civil societies to promote transparency and accountability with regard to those steps and support their implementation.
• As an important step to scaling up towards the goal of UA to HIV/AIDS prevention, treatment, care and support in Africa, G8 members, in support of national HIV/AIDS programs globally, individually and collectively over the next few years will aim to employ existing and additional programs to support life-saving anti-retroviral treatment through bilateral and multilateral efforts for approximately five million people, to prevent twenty-four million new infections, and to care for twenty-four million people, including ten million orphans and vulnerable children.
• In view of the G8 countries contributions to achieving the health related international goals we agreed in St. Petersburg to review the progress in this regard, including our financial commitments, in fighting the three diseases HIV/AIDS, tuberculosis and malaria, regularly. We will undertake this monitoring exercise for the first time this year under the Presidency's guidance. The report will inform our activities and commitments and we affirm that we will continue this close monitoring process regularly.
• The G8 welcome innovative financing initiatives.

• we will work with African governments and donors to strengthen the effectiveness of their malaria control programs in Africa along the three main intervention lines of artemisinin combination therapy, effective case management, effective, tailored vector control strategies and bednets.
• We recognize the significant role and contribution of the Global Fund and other bilateral, multilateral and private partners of the international community, such as the World Bank Malaria Booster Program and the U.S. President's Malaria Initiative, which provide substantive funding towards reaching this goal.
• G8 members, in support of national malaria control programs, using existing and additional funds, will individually and collectively over the next few years work to enable the 30 highest malaria prevalence countries in Africa reach at least 85 percent coverage of the most vulnerable groups with effective prevention and treatment measures and achieve a 50 percent reduction in malaria related deaths.To accelerate implementation of the financial commitments we have undertaken at Gleneagles, we will work to reach this goal by mobilizing the private sector and its expertise and resources, enhancing public awareness, encouraging public-private partnerships, and urging non-G8 countries to do the same.

• We are committed to working toward further integration of efforts against TB and HIV/AIDS and the integration of DOTS-treatment and other comprehensive approaches necessary to control TB in our programs and activities in order to alleviate the burden of the co-pandemic

• In the overall context of scaling up towards the goal of universal access and strengthening of health systems we will contribute substantially　with other donors to work towards the goal of providing universal coverage of PMTCT programs by 2010. The cost to reach this target, as estimated by UNICEF, is US$ 1,5 billion. The G8 together with other donors will work towards meeting the needed resources for paediatric treatments in the context of universal access, at a cost of US$ 1,8 billion till 2010, estimated by UNICEF. We will also scale up efforts to reduce the gaps, in the area of maternal and child health care and voluntary family planning, an estimated US$ 1,5 billion.

• The G8 will take concrete steps to support education programs especially for girls, to promote knowledge about sexuality and RH and the prevention of STI.

• We welcome previous commitments by African countries to increase the share of their budgets devoted to the health sector and look forward to continued progress in meeting these targets, and appeal to bilateral donors, to multilateral development banks (World Bank and the African Development Bank), the WHO and the global initiatives in the health sector to assist and align on country led processes in line with the agreements of the Paris Declaration of March 2005 and to provide targeted support to African health system development. In this context, the G8 will enhance coordination of bilateral and multilateral health partnerships with national health strategies (Scaling Up for Better Health process) and appeal to the World Bank and the WHO to support country driven harmonization processes in the health sector in cooperation with the African Development Bank and the African Union as well as other relevant international organizations.
• Based on the St. Petersburg declaration and noting the Paris conference in March 2007, the G8 support the establishment by African countries of sustainable financing of health systems. Enhancing this process, the G8 welcome the "Providing for Health" initiative as a means to work toward sustainable and equitable financing of health systems and improved access to quality health services, through linking national financing strategies with coordinated international support.
• We will work with African states to address the different causes of this lack of human resource capacity within the health sector, including working conditions and salaries with the aim of recruiting, training and retaining additional health workers. We will also work with national governments as they endeavor to create an environment where its most capable citizens, including medical doctors and other healthcare workers, see a long-term future in their own countries. We will work with the Global Health Workforce Alliance, interested private parties, the OECD and the WHO to build the evidence base on health workforce management and international migration.

• G8 members pledge to work with other donors to replenish the GFATM and to provide long-term predictable funding based on ambitious, but realistic demand-driven targets.
• G8 partners will work with other stakeholders so that GFATM resources continue to be used in alignment with existing national priorities and processes.
• G8 in cooperation with partner governments support a gender-sensitive response by the GFATM, with the goal of ensuring that greater attention and appropriate resources are allocated by the Fund to HIV/AIDS prevention, treatment, and care that addresses the needs of women and girls.

• will make utmost efforts in cooperation with IO and partners to eradicate polio and will also work with others to close urgent funding shortfalls.

• The G8 will continue our efforts towards these goals (UA, MDG for fighting HIV/AIDS, TB and Malaria on a sustainable basis and strengthening healht systems) to provide at least a projected US$ 60 billion over the coming years, and invite other donors to contribute as...